A new whole genome amplification method for studying clonal evolution patterns in malignant colorectal polyps

Genes Chromosomes and Cancer

Volumn 51, Issue 5, 2012, Pages 490-500

  Hirsch, Daniela ^a   Camps, Jordi ^a   Varma, Sudhir ^b   Kemmerling, Ralf ^c   Stapleton, Mark ^d   Ried, Thomas ^a   Gaiser, Timo ^a,e  

^a NATIONAL CANCER INSTITUTE   (United States)

^b HiThru Analytics   (United States)

^c PARACELSUS MEDICAL UNIVERSITY   (Austria)

^d NuGEN Technologies Inc   (United States)

^e UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FORMALDEHYDE; PARAFFIN;

AGE; ARTICLE; CANCER GRADING; CHROMOSOME 18Q; CHROMOSOME 20Q; CHROMOSOME 5Q; CHROMOSOME ABERRATION; CHROMOSOME ARM; CHROMOSOME LOSS; CLINICAL ARTICLE; CLONAL EVOLUTION; COLON ADENOCARCINOMA; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA DEGRADATION; DNA FRAGMENTATION; GENE AMPLIFICATION; GENOMIC INSTABILITY; HUMAN; HUMAN TISSUE; ISOTHERM; PRIORITY JOURNAL; SIGNAL NOISE RATIO; TUMOR GROWTH; WHOLE GENOME AMPLIFICATION;

ADENOMA; CARCINOMA; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 20; CLONAL EVOLUTION; COLONIC POLYPS; COLORECTAL NEOPLASMS; COMPARATIVE GENOMIC HYBRIDIZATION; DNA COPY NUMBER VARIATIONS; DNA, NEOPLASM; HUMANS;

EID: 84857997501     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.21937     Document Type: Article

References (30)

1. Alcock HE, Stephenson TJ, Royds JA, Hammond DW. 2003. Analysis of colorectal tumor progression by microdissection and comparative genomic hybridization. Genes Chromosome Cancer 37: 369-380.
2. Bardi G, Johansson B, Pandis N, Bak-Jensen E, Orndal C, Heim S, Mandahl N, Andren-Sandberg A, Mitelman F. 1993a. Cytogenetic aberrations in colorectal adenocarcinomas and their correlation with clinicopathologic features. Cancer 71: 306-314.
3. Bardi G, Johansson B, Pandis N, Mandahl N, Bak-Jensen E, Lindstrom C, Tornqvist A, Frederiksen H, Andren-Sandberg A, Mitelman F, Heim S. 1993b. Cytogenetic analysis of 52 colorectal carcinomas-Nonrandom aberration pattern and correlation with pathologic parameters. Int J Cancer 55: 422-428.
4. Bardi G, Pandis N, Fenger C, Heim S. 1995. Trisomy 7 as the sole cytogenetic aberration in the epithelial component of a colonic adenoma. Cancer Genet Cytogenet 82: 82-84.
5. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Ser B Stat Methodol 57: 289-300.
6. Boland CR, Sato J, Appelman HD, Bresalier RS, Feinberg AP. 1995. Microallelotyping defines the sequence and tempo of allelic losses at tumour suppressor gene loci during colorectal cancer progression. Nat Med 1: 902-909.
7. Bosso M, Al-Mulla F. 2011. Whole genome amplification of DNA extracted from FFPE tissues. Methods Mol Biol 724: 161-180.
8. Carvalho B, Postma C, Mongera S, Hopmans E, Diskin S, van de Wiel MA, van Criekinge W, Thas O, Matthai A, Cuesta MA, Terhaar Sive Droste JS, Craanen M, Schrock E, Ylstra B, Meijer GA. 2009. Multiple putative oncogenes at the chromosome 20q amplicon contribute to colorectal adenoma to carcinoma progression. Gut 58: 79-89.
9. Fearon ER, Vogelstein B. 1990. A genetic model for colorectal tumorigenesis. Cell 61: 759-767.
10. Gaiser T, Camps J, Meinhardt S, Wangsa D, Nguyen QT, Varma S, Dittfeld C, Kunz-Schughart LA, Kemmerling R, Becker MR, Heselmeyer-Haddad K, Ried T. 2011. Genome and transcriptome profiles of CD133-positive colorectal cancer cells. Am J Pathol 178: 1478-1488.
11. Grade M, Becker H, Liersch T, Ried T, Ghadimi BM. 2006. Molecular cytogenetics: Genomic imbalances in colorectal cancer and their clinical impact. Cell Oncol 28: 71-84.
12. Habermann JK, Paulsen U, Roblick UJ, Upender MB, McShane LM, Korn EL, Wangsa D, Kruger S, Duchrow M, Bruch HP, Auer G, Ried T. 2007. Stage-specific alterations of the genome, transcriptome, and proteome during colorectal carcinogenesis. Genes Chromosome Cancer 46: 10-26.
13. Habermann JK, Doering J, Hautaniemi S, Roblick UJ, Bundgen NK, Nicorici D, Kronenwett U, Rathnagiriswaran S, Mettu RK, Ma Y, Kruger S, Bruch HP, Auer G, Guo NL, Ried T. 2009. The gene expression signature of genomic instability in breast cancer is an independent predictor of clinical outcome. Int J Cancer 124: 1552-1564.
14. Heim S, Mitelman F. 2009. Cancer Cytogenetics. Hoboken: Wiley.
15. Hughes S, Arneson N, Done S, Squire J. 2005. The use of whole genome amplification in the study of human disease. Prog Biophys Mol Biol 88: 173-189.
16. Isola J, DeVries S, Chu L, Ghazrini S, Waldman F. 1994. Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples. Am J Pathol 145: 1301-1308.
17. Johnson NA, Hamoudi RA, Ichimura K, Liu L, Pearson DM, Collins VP, Du MQ. 2006. Application of array CGH on archival formalin-fixed paraffin-embedded tissues including small numbers of microdissected cells. Lab Invest 86: 968-978.
18. Klein CA, Stoecklein NH. 2009. Lessons from an aggressive cancer: Evolutionary dynamics in esophageal carcinoma. Cancer Res 69: 5285-5288.
19. Little SE, Vuononvirta R, Reis-Filho JS, Natrajan R, Iravani M, Fenwick K, Mackay A, Ashworth A, Pritchard-Jones K, Jones C. 2006. Array CGH using whole genome amplification of fresh-frozen and formalin-fixed, paraffin-embedded tumor DNA. Genomics 87: 298-306.
20. Meijer GA, Hermsen MA, Baak JP, van Diest PJ, Meuwissen SG, Belien JA, Hoovers JM, Joenje H, Snijders PJ, Walboomers JM. 1998. Progression from colorectal adenoma to carcinoma is associated with nonrandom chromosomal gains as detected by comparative genomic hybridization. J Clin Pathol 51: 901-909.
21. Pinkel D, Albertson DG. 2005. Array comparative genomic hybridization and its applications in cancer. Nat Genet 37( Suppl): S11-S17.
22. Ried T, Just KE, Holtgreve-Grez H, du Manoir S, Speicher MR, Schrock E, Latham C, Blegen H, Zetterberg A, Cremer T, Auer G. 1995. Comparative genomic hybridization of formalin-fixed, paraffin-embedded breast tumors reveals different patterns of chromosomal gains and losses in fibroadenomas and diploid and aneuploid carcinomas. Cancer Res 55: 5415-5423.
23. Ried T, Knutzen R, Steinbeck R, Blegen H, Schrock E, Heselmeyer K, du Manoir S, Auer G. 1996. Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors. Genes Chromosome Cancer 15: 234-245.
24. Ried T, Heselmeyer-Haddad K, Blegen H, Schrock E, Auer G. 1999. Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: A phenotype/genotype correlation. Genes Chromosome Cancer 25: 195-204.
25. Schulze S, Petersen I. 2011. Gender and ploidy in cancer survival. Cell Oncol (Dordr) 34: 199-208.
26. Speicher MR, du Manoir S, Schrock E, Holtgreve-Grez H, Schoell B, Lengauer C, Cremer T, Ried T. 1993. Molecular cytogenetic analysis of formalin-fixed, paraffin-embedded solid tumors by comparative genomic hybridization after universal DNA-amplification. Hum Mol Genet 2: 1907-1914.
27. Srinivasan M, Sedmak D, Jewell S. 2002. Effect of fixatives and tissue processing on the content and integrity of nucleic acids. Am J Pathol 161: 1961-1971.
28. Stoecklein NH, Klein CA. 2010. Genetic disparity between primary tumours, disseminated tumour cells, and manifest metastasis. Int J Cancer 126: 589-598.
29. Tanabe C, Aoyagi K, Sakiyama T, Kohno T, Yanagitani N, Akimoto S, Sakamoto M, Sakamoto H, Yokota J, Ohki M, Terada M, Yoshida T, Sasaki H. 2003. Evaluation of a whole-genome amplification method based on adaptor-ligation PCR of randomly sheared genomic DNA. Genes Chromosome Cancer 38: 168-176.
30. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL. 1988. Genetic alterations during colorectal-tumor development. N Engl J Med 319: 525-532.